Skip to Content

Join the 'Idiopathic Pulmonary Fibrosis' group to help and get support from people like you.

Idiopathic Pulmonary Fibrosis News

Related terms: IPF

Health Tip:Living with Pulmonary Fibrosis

Posted 14 Feb 2018 by Drugs.com

-- Pulmonary fibrosis is a disease that can lead to scarring in air sacs within the lungs. This can make breathing difficult. Most cases of the disease have no known cause, and its severity varies from person to person. About 140,000 Americans have been diagnosed with pulmonary fibrosis, the American Lung Association says. Here are the group's suggestions for managing the disease: Take all ...

Esbriet and Ofev Approved to Treat Idiopathic Pulmonary Fibrosis

Posted 16 Oct 2014 by Drugs.com

THURSDAY, Oct. 16, 2014 – Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF). Approval was given to Esbriet (pirfenidone) and Ofev (nintedanib), the agency said in news releases on Wednesday. Symptoms of IPF include shortness of breath, cough and difficulty ...

FDA Approves Ofev (nintedanib) for Idiopathic Pulmonary Fibrosis

Posted 15 Oct 2014 by Drugs.com

October 15, 2014 – The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a condition in which the lungs become progressively scarred over time. As a result, patients with IPF experience shortness of breath, cough, and have difficulty participating in everyday physical activities. Current ...

FDA Approves Esbriet (pirfenidone) for Idiopathic Pulmonary Fibrosis

Posted 15 Oct 2014 by Drugs.com

October 15, 2014 – The U.S. Food and Drug Administration today approved Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a condition in which the lungs become progressively scarred over time. As a result, patients with IPF experience shortness of breath, cough, and have difficulty participating in everyday physical activities. ...

Scientists Spot New Clues to a Deadly Lung Disease

Posted 11 Jun 2014 by Drugs.com

WEDNESDAY, June 11, 2014 – Scientists believe they've found a key biological player in idiopathic pulmonary fibrosis (IPF), a uniformly fatal lung disease that kills thousands of Americans each year. The finding may be another step forward for patients who have typically had a bleak prognosis. Last month, studies revealed that two new medications might offer some hope for the first effective ...

Two Drugs Offer Hope for Fatal Lung Disease

Posted 18 May 2014 by Drugs.com

SUNDAY, May 18, 2014 – A pair of drugs offers new hope to patients with a progressive, fatal disease that robs their breath by scarring the lungs, according to clinical trial results. Both drugs, pirfenidone and nintedanib, appear to slow the advance of idiopathic pulmonary fibrosis, or IPF, an incurable and previously untreatable disease that causes tissue deep in the lungs to stiffen and scar. ...

Ask a Question

Further Information

Related Condition Support Groups

Pulmonary Fibrosis

Related Drug Support Groups

Ofev, nintedanib, pirfenidone, Esbriet, interferon gamma-1b, Actimmune